Medtronic (NYSE:MDT) today announced successful results from its STOP AF First clinical trial for cryoablation treatment. Published in the New England Journal of Medicine, results showed that cryoablation with the Arctic Front Advance Cardiac Cryoballoon and Freezor MAX cardiac cryoablation catheter is superior as a first-line treatment for preventing atrial arrhythmia recurrence compared to the use […]
Catheters
Acutus appoints chief translational science officer
Acutus Medical (NSDQ:AFIB) announced that it appointed Dr. Steven Mickelsen as its chief translational science officer. Carlsbad, Calif.-base Acutus, which develops cardiac mapping technology, said in a news release that Mickelsen is set to guide the company’s vision to deliver the “most advanced electrophysiology therapeutic solutions on the market for physicians and their patients.” Mickelsen […]
Medtronic has a Class I recall involving balloon catheters to treat heart defects
FDA today designated a Medtronic recall of Rashkind balloon septostomy catheters as Class I, its most serious level. The balloon catheters create an atrial septal defect or to enlarge an existing atrial septal defect in order to treat congenital heart defects. Medtronic (NYSE:MDT) initiated a recall of the Rashkind balloon septostomy catheters in late August after […]
Abbott launches next-gen 3D cardiac mapping platform in Europe, Australia
Abbott (NYSE:ABT) announced today that it received CE Mark and Australian approval for its new EnSite X EP system. EnSite X EP is touted as the only system that allows for navigation of the cardiac anatomy in two different ways through the same lone platform. The new cardiac mapping platform builds upon Abbott’s electrophysiology portfolio with […]
J&J wins FDA approval for ablation catheter
Johnson & Johnson (NYSE:JNJ) recently announced that its Biosense Webster business has secured FDA approval for its Thermocool SmartTouch SF ablation catheter. The Thermocool SmartTouch received approval for the treatment of persistent atrial fibrillation, J&J announced yesterday. Get the full story on our sister site Medical Tubing + Extrusion.
Mentice to buy Vascular Simulations
Mentice (STO: MNTC) recently announced that it has agreed to acquire New York-based Vascular Simulations (VSI). The financial terms of the deal were not disclosed in the Oct. 1 announcement. VSI provides portable vessel models that enable doctors to manipulate real medical devices within a physical 3D structure that replicates the human body’s vessel structure. Get the […]
Medtronic to acquire Avenu Medical
Medtronic (NYSE:MDT) announced today that it plans to acquire endovascular arteriovenous (AV) fistulae creator Avenu Medical. Terms of the transaction were not disclosed by the medtech giant or the soon-to-be acquired San Juan Capistrano, Calif.-based company, which focuses on the endovascular creation of AV fistulae for patients with end-stage renal disease (ESRD) undergoing dialysis, according to […]
Coloplast invests $4M in Francis Medical
Urological cancer treatment developer Francis Medical announced today that it received a $4 million equity investment from Coloplast (CPH:COLO-B). Minneapolis-based Francis Medical develops ablation technology designed to apply thermal energy stored in sterile water vapor to deliver targeted treatments to the cancerous tissue in a transurethral procedure, according to a news release. The procedure potentially minimizes […]
AngioDynamics jumps on Street-beating Q1
AngioDynamics (NSDQ:ANGO) shares skyrocketed today on first-quarter results that topped the consensus forecast. Shares of ANGO were up 13.2% at $12.01 per share in mid-morning trading today. The Latham, N.Y.-based peripheral artery disease (PAD) treatment developer posted losses of -$4.3 million, or -11¢ per share, on sales of $70.2 million for the three months ended Aug. […]
Boston Scientific launches aortic valve system in Europe
Boston Scientific (NYSE:BSX) announced today that it began a controlled launch of its Acurate neo2 aortic valve system in Europe. Marlborough, Mass.-based Boston Scientific’s next-generation transcatheter aortic valve implantation (TAVI) technology is designed to improve upon the original version of the Acurate neo platform. Acurate neo2 has expanded indication for patients with aortic stenosis (with no […]
The top 5 MassDevice stories of the week — September 25, 2020
The past week in medtech saw Boston Scientific (NYSE:BSX) make an interesting move in the Afib space — and much more. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top […]
